ARS Pharmaceuticals
Maker of the first FDA-approved needle-free nasal spray for severe allergic reactions.
$5.99
After-hours close+0.10 (+1.78%)
At close$5.89(−2.40%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 92.12%Insiders 15.11%
Institutions and insiders are filed separately and overlap, so together they can pass the whole company. No split is drawn from them.
Shares outstanding 99.30M · Float 64.50M · 65.0% free float
Institutions13F, as of Jun 30, 2026
214 holders · 91.48M shares · 40 new positions · 116 increased · 53 reduced · 34 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 10.86M | 10.94% | 0 | Aug 14, 2026 |
| Rubric Capital Management LP | 8.54M | 8.60% | +540.9K | Aug 14, 2026 |
| Orbimed Advisors LLC | 8.29M | 8.35% | 0 | Aug 14, 2026 |
| Deerfield Management Company, L.P. (Series C) | 7.50M | 7.56% | 0 | Aug 14, 2026 |
| BlackRock, Inc. | 5.31M | 5.35% | +299.1K | Aug 7, 2026 |
| Tyro Capital Management LLC | 4.46M | 4.49% | +1.49M | Aug 13, 2026 |
| Abrdn PLC | 4.17M | 4.20% | +57.0K | Jul 31, 2026 |
| Sr One Capital Management, LP | 4.01M | 4.04% | 0 | Aug 12, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| RA Capital Management, L.P.incl. RA Capital Healthcare Fund, L.P., Peter Kolchinsky +1 more | 11.10% | 10.94M | 13D | Oct 1, 2025 ↗ |
| Rubric Capital Management LP | 8.06% | 8.00M | 13G | May 15, 2026 ↗ |
| Deerfield Management Company, L.P.incl. Deerfield Mgmt III, L.P., Deerfield Private Design Fund III, L.P. +3 more | 7.75% | 7.61M | 13D | Aug 1, 2025 ↗ |
| Millennium Management LLC | 5.40% | 5.39M | 13G | Mar 24, 2026 ↗ |
| BlackRock, Inc. | 5.30% | 5.22M | 13G | Jul 27, 2026 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Richard E. Lowenthal | director, 10 percent owner, officer: PRESIDENT AND CEO | 5.52M | 5.56% | Aug 22, 2025 |
| Flynn James E | 10 percent owner | 4.89M | 4.92% | Jul 1, 2025 |
| Sarina Tanimoto | 10 percent owner, officer: CHIEF MEDICAL OFFICER | 4.67M | 4.70% | Aug 21, 2025 |
| Pratik Shah | director | 4.47M | 4.51% | Nov 14, 2025 |
| Laura Shawver | director | 210.3K | 0.21% | Apr 8, 2025 |
| Alexander A. Fitzpatrick | officer: Chief Legal Officer | 90.9K | 0.09% | Jun 12, 2026 |
| Eric Karas | officer: Chief Commercial Officer | 12.2K | 0.01% | Jun 12, 2026 |
| Brian Dorsey | officer: Chief Operating Officer | 10.8K | 0.01% | Nov 14, 2025 |
| Kathleen D. Scott | officer: Chief Financial Officer | 10.0K | 0.01% | Aug 22, 2025 |
1 ten-percent owner holds 4.89M shares by Form 4, outside the officers-and-directors figure above · 3 people have not refiled in the last 18 months (21.50M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Jun 12, 2026 | Alexander A. Fitzpatrickofficer: Chief Legal Officer | Sale | 3,355 | $10.00 | 90,910 |
| Jun 12, 2026 | Eric Karasofficer: Chief Commercial Officer | Sale | 25,000 | $10.00 | 12,176 |
| Nov 12, 2025 | Justin Chakmaofficer: Chief Business Officer | Sale · 2 lots | 166,380 | $8.87 | 0 |
| Nov 13, 2025 | Brian Dorseyofficer: Chief Operating Officer | Sale | 21,828 | $8.71 | 10,789 |
CongressHouse and Senate disclosures
Not reported.